Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients

Shu-Yu Yao; Paul T. Kocis; Terrence Murphy; Wenke Hwang

doi:10.3390/pharma4010006

Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	6
Journal	Pharmacoepidemiology
Volume	4
Issue number	1
DOIs	https://doi.org/10.3390/pharma4010006
State	Published - 2025

Access to Document

10.3390/pharma4010006

Cite this

@article{f8d3e4c0bc75484b84c08c23fb75f12e,

title = "Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients",

author = "Shu-Yu Yao and Kocis, \{Paul T.\} and Terrence Murphy and Wenke Hwang",

year = "2025",

doi = "10.3390/pharma4010006",

language = "English (US)",

volume = "4",

pages = "6",

journal = "Pharmacoepidemiology",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "1",

}

TY - JOUR

T1 - Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients

AU - Yao, Shu-Yu

AU - Kocis, Paul T.

AU - Murphy, Terrence

AU - Hwang, Wenke

PY - 2025

Y1 - 2025

U2 - 10.3390/pharma4010006

DO - 10.3390/pharma4010006

M3 - Article

VL - 4

SP - 6

JO - Pharmacoepidemiology

JF - Pharmacoepidemiology

IS - 1

ER -